geneiusbiotech.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.geneiusbiotech.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	HOME \|
Description	Geneius is developing transformative personalized targeted T cell therapies for Geneius develops transformative personalized targeted T cell therapies for
Keywords	N/A

Server Information

WebSite	geneiusbiotech.com
Host IP	185.230.63.186
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

geneiusbiotech.com Valuation

US$1,061

Last updated: 2023-05-11 17:54:51

geneiusbiotech.com has Semrush global rank of 0. geneiusbiotech.com has an estimated worth of US$ 1,061, based on its estimated Ads revenue. geneiusbiotech.com receives approximately 122 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, geneiusbiotech.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,061
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$29
Yearly Ads Revenue	US$352
Daily Unique Visitors	8
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
geneiusbiotech.com.	A	3599	IP: 185.230.63.186
geneiusbiotech.com.	A	3599	IP: 185.230.63.107
geneiusbiotech.com.	A	3599	IP: 185.230.63.171
geneiusbiotech.com.	NS	86400	NS Record: ns12.wixdns.net.
geneiusbiotech.com.	NS	86400	NS Record: ns13.wixdns.net.

HtmlToTextCheckTime:2023-05-11 17:54:51

top of page HOME LEADERSHIP TECHNOLOGY CLINICAL PIPELINE NEWS CONTACT Geneius is developing transformative personalized targeted T cell therapies for cancers. CONTACT US Geneius Biotechnology 12 Michigan Drive Natick, MA 01760 Ph: (781) 856-7589 Success! Message received. Send contact GENEIUS is focused on the development & commercialization of innovative autologous, adoptive T-cell therapies, which offer a more robust immune response to cancer compared to current approaches. Clinical Efficacy in Human Trials An academic sponsored, proof-of-concept study of the same T cells showed: 70% overall response rate (ORR); and 50% complete response (CR) with complete remissions after 5 years for half of those patients in human, clinical trials. We believe that prior academic results, as well as our preclinical and manufacturing data suggest a high probability of success in Epstein-Barr Virus (EBV+) lymphoma. Works in Solid Tumors Evidence of efficacy in solid tumors; and Highly durable

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Tue, 09 Nov 2021 08:45:22 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.geneiusbiotech.com/
strict-transport-security: max-age=120
Age: 44928
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi9UwUuevlgidOw7LozzCz1,m0j2EEknGIVUW/liY8BLLk1Uxi5aVwrmRyfWZ8T7SgAMbwluI1yUDJty9McxOlfY,2d58ifebGbosy5xc+FRalkTdB6W5lqEQNd/ZOw4XmNZIz+5ivzTL00x2v5GbrrPffdK+gjY1t8zRE7ws4vlhig==,2UNV7KOq4oGjA5+PKsX47HYXd6zDG0Q4ZvIB35CKuI8fbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1636447522.1731008765281127198
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Tue, 09 Nov 2021 08:45:22 GMT
content-type: text/html; charset=UTF-8
content-length: 424399
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"52a2bb3c700ba55cf90f611d6c3c856c"
content-language: en
strict-transport-security: max-age=120
age: 28403
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMd0qnhlQ7CKiS1i9ukj0dSj,qquldgcFrj2n046g4RNSVGuzUR+ZX0KpeYRQjJYRPxRYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRalok4RQ0ADVJ0k/uunT/Kw3nlrXvx8gzYrhzAq94m1+izSf524lPwTgDbn82fURSkbiz9geDUE8988Qps0IIo4VE=,2UNV7KOq4oGjA5+PKsX47BKn5Yg4ON9Aa7djl3ltpSdYgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1636447522.309154850681414757
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=usc1_g; Max-Age=20; Expires=Tue, 09 Nov 2021 08:45:42 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=usc1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

geneiusbiotech.com Whois Information

Domain Name: GENEIUSBIOTECH.COM
Registry Domain ID: 2503432592_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.wix.com
Registrar URL: http://www.wix.com
Updated Date: 2021-03-08T00:22:07Z
Creation Date: 2020-03-14T18:42:54Z
Registry Expiry Date: 2022-03-14T18:42:54Z
Registrar: Wix.com Ltd.
Registrar IANA ID: 3817
Registrar Abuse Contact Email: domain-abuse@wix.com
Registrar Abuse Contact Phone: +14154291173
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS12.WIXDNS.NET
Name Server: NS13.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-11-09T07:28:16Z <<<

geneiusbiotech.com valuation and analysis